Abstract
Sophorolipids, a kind of glycolipids, regarded as the most promising bio-surfactant, are synthesized by a selected number of yeast species. Instead of offering, as an environmental friendly alternative to the petrochemical based surfactants, it also exhibits various bioactivities. Sophorolipids in particular are on the brink of being incorporated into several cosmetic application. The potential of this molecule is also screened in various industries like the cosmetics, pharmaceuticals, and other medical applications. In this review, our aim is to provide an overview and updates on basic and applied research on Sophorolipid especially in terms of cosmetics and medicinal uses.
Keywords: Sophorolipid, Antibacterial, Anticancer, Cosmetics.
Mini-Reviews in Medicinal Chemistry
Title:Medicinal and Cosmetic Potentials of Sophorolipids
Volume: 13 Issue: 12
Author(s): V.K. Morya, Changha Ahn, Sanggui Jeon and Eun-Ki Kim
Affiliation:
Keywords: Sophorolipid, Antibacterial, Anticancer, Cosmetics.
Abstract: Sophorolipids, a kind of glycolipids, regarded as the most promising bio-surfactant, are synthesized by a selected number of yeast species. Instead of offering, as an environmental friendly alternative to the petrochemical based surfactants, it also exhibits various bioactivities. Sophorolipids in particular are on the brink of being incorporated into several cosmetic application. The potential of this molecule is also screened in various industries like the cosmetics, pharmaceuticals, and other medical applications. In this review, our aim is to provide an overview and updates on basic and applied research on Sophorolipid especially in terms of cosmetics and medicinal uses.
Export Options
About this article
Cite this article as:
Morya V.K., Ahn Changha, Jeon Sanggui and Kim Eun-Ki, Medicinal and Cosmetic Potentials of Sophorolipids, Mini-Reviews in Medicinal Chemistry 2013; 13 (12) . https://dx.doi.org/10.2174/13895575113139990002
DOI https://dx.doi.org/10.2174/13895575113139990002 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Targeting Strategies in Cancer Treatment: An Overview
Mini-Reviews in Medicinal Chemistry “Letting the Air In” Can Set the Stage for Tumor Recurrences
Current Cancer Therapy Reviews Biological Significance of Polymorphism in Legume Protease Inhibitors from the Bowman-Birk Family
Current Protein & Peptide Science CCK Receptors and Cancer
Current Topics in Medicinal Chemistry Cannabis-Derived Substances in Cancer Therapy – An Emerging Anti- Inflammatory Role for the Cannabinoids
Current Clinical Pharmacology Circumventing Immune Tolerance Through Epigenetic Modification
Current Pharmaceutical Design Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance
Anti-Cancer Agents in Medicinal Chemistry Dietary Polyphenols for Prostate Cancer Therapy
Current Bioactive Compounds The Development of Epigenetics and Related Inhibitors for Targeted Drug Design in Cancer Therapy
Current Topics in Medicinal Chemistry Chemical Properties and Mechanisms Determining the Anti-Cancer Action of Garlic-Derived Organic Sulfur Compounds
Anti-Cancer Agents in Medicinal Chemistry Cancer Chemoprevention by Targeting the Epigenome
Current Drug Targets Subject Index To Volume 7
Current Pharmaceutical Design KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker
Combinatorial Chemistry & High Throughput Screening RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer
Current Cancer Drug Targets Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies
Current Molecular Medicine HGF/MET Signaling in Ovarian Cancer
Current Molecular Medicine The Role of the Antiangiogenetic Ramucirumab in the Treatment of Advanced Non Small Cell Lung Cancer
Current Medicinal Chemistry Future Prospect of RNA Interference for Cancer Therapies
Current Drug Targets Metallothioneins and Cancer
Current Protein & Peptide Science A Molecular Link Between Diabetes and Breast Cancer: Therapeutic Potential of Repurposing Incretin-based Therapies for Breast Cancer
Current Cancer Drug Targets